Tags » Patent

Corruption tars drug industry drive to improve access for poor; GlaxoSmithKline retains top spot

Source: Economic Times

November 17,2014

LONDON: The world’s top drugmakers have improved access to medicines in developing countries, according to a report on Monday, but their good work is undermined by a sorry record of unethical behaviour. 326 more words

Access To Medicines

Pharma Trade Group Head Causes a Stir With a Remark About Patents

Source: WSJ Pharmalot

November 17,2014

File this under ‘Nothing like getting off to a good start.’

Last week, Stefan Oschmann, the chief executive officer at Merck KGgA, was elected president of the International Federation of Pharmaceutical Manufacturers Association, a trade group for drug makers that is based in Europe. 899 more words

Access To Medicines

South Centre concerned over US pressure on India's IP regime

Source: TWN

Geneva, 11 Nov (Kanaga Raja) — The South Centre has expressed concern
over the pressures being placed on India by the United States Trade… 2,936 more words

Access To Medicines

What’s Trending in Patents? Illegality for cross-undertakings, Teva v Leo, Wearables, Generics Litigation, China and Innovation Statistics

1. The recent UK Supreme Court decision Servier v Apotex concerned whether patent infringement in another territory is an ‘illegality’ which would be relevant to payment of cross-undertakings. 243 more words

Patent

Pharmaceutical industry gets high on fat profits

Source: BBC News

11 Nov 2014

Imagine an industry that generates higher profit margins than any other and is no stranger to multi-billion dollar fines for malpractice. 1,308 more words

Patent

Reasons to go to Mediation in a Pharma Patent Dispute

Michael Fysh spoke at fieldfisher’s Pharma Seminar on 16 October 2014. The following points are based on the handout he gave at the event.

Advantages of Mediation in General and in Pharma Cases… 310 more words

Patent

EU Pharma Patent Settlements

These points are from a talk given by John Cassels at fieldfisher’s Pharma Patents Seminar on 16 October 2014.

  1. Anticompetitive behaviour can arise either due to agreements between parties or from unilateral behaviour, and patent settlements are agreements that may be anticompetitive.
  2. 207 more words
Patent